According to Xilio Therapeutics's latest financial reports the company's current earnings (TTM) are -โฌ61.99 M. In 2022 the company made an earning of -โฌ80.45 M a decrease over its 2021 earnings that were of -โฌ67.72 M.The earnings displayed on this page is the company's Pretax Income.